Study of the Effects on DNA of Two Novel Nucleoside Derivatives Synthesized as Potential Anti-HIV Agents

REFERENCES

• Borrello L., Iannazzo D., Merino P., Piperno A., Rescifina A., Richichi B., Romeo G. Enantioselective synthesis of N,O, psiconucleosides. Tetrahedron: Asymmetry 2003; 14: 2419–2425
   Web of Science ®Google Scholar
• Chiachio U., Debella M. R., Rescifina A., Romeo G., Ucella N. A new synthesis of Streptomyces lactones by 1,3-dipolar cycloaddition. Heterocycles 1993; 36: 2209–2213
   Web of Science ®Google Scholar
• Chiachio U., Gumina G., Rescifina A., Romeo R., Ucella N., Casuscelli F., Piperno A., Romeo G. Modified Dideoxynucleosides: synthesis of 2′-N-Alkyl-3′-hydroxyalkyl-1′2′-isoxazolidinyl thymidine and 5-fluoruridine derivatives. Tetrahedron 1996; 52: 8889
   Web of Science ®Google Scholar
• Chiacchio U., Borrello L., Iannazzo D., Merino P., Piperno A., Rescifina A., Richichi B., Romeo G. Enantioselective synthesis of N,O psiconucleosides. Tetrahedron: Asymmetry 2003a; 14: 2419–2425
   Web of Science ®Google Scholar
• Chiacchio U., Corsaro A., Iannazzo D., Piperno A., Pistara' V., Rescifina A., Romeo R., Sindona G., Romeo G. Diastereo and enantioselective synthesis of N,O-nucleosides. Tetrahedron: Asymmetry 2003b; 14: 2717–2723
   Web of Science ®Google Scholar
• De Clercq E. HIV resistance to reverse transcriptase inhibitors. Biochem. Pharmacol 1994; 47: 155–169
   PubMed Web of Science ®Google Scholar
• De Clercq E. Strategies in the development of antiviral drugs. Nat. Rev 2002a; 1: 13–25
   Google Scholar
• De Clercq E. New developments in anti-HIV chemotherapy. Biochim. Biophys. Acta 2002b; 1587: 258–275
   PubMed Web of Science ®Google Scholar
• De Clercq E. New anti-HIV agents and targets. Med. Res. Rev 2002c; 22: 531–565
   PubMed Web of Science ®Google Scholar
• De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol 2004; 30: 115–133
   PubMed Web of Science ®Google Scholar
• Gichner T., Vousinas G., Patrineli A., Kappas A., Plewa M. Antimutagenicity of three isomers of aminobenzoic acid in. Salmonella typhimurium. Mutat. Res 1994; 309: 201
   PubMed Web of Science ®Google Scholar
• Origin of Human Cancer, H. H. Hiatt, J. D. Watson, J. W. Winsten. Cold Spring Harbor Lab, Cold Spring Harbor, New York 1977; 697–707
   Google Scholar
• Jonckheere H., Anne J., De Clercq E. The HIV-1 reverse transcription (RT) process as target for RT inhibitors. Med. Res. Rev 2000; 20: 129–154
   PubMed Web of Science ®Google Scholar
• Katz R. A., Skalka A. M. The retroviral enzymes. Annu. Rev. Biochem 1994; 63: 133–173
   PubMed Web of Science ®Google Scholar
• Kopsidas G., MacPhee D. G. Frameshift mutagenesis by 9-aminoacridine: antimutagenic effects of adenosine compounds. Mutat. Res. 10; 1996; 352(1)135–142
   PubMed Web of Science ®Google Scholar
• Lee H., Lin J. Y. Antimutagenic activity of extracts from anticancer drugs in Chinese medicine. Mutat. Res 1988; 204(2)229–34
   PubMed Web of Science ®Google Scholar
• Macchi B., Balestrieri E., Mastino A. Effects of nucleoside-based anti-retroviral chemotherapy on human T-cell leukaemia/lymphotropic virus type-1 (HTLV- 1). J. Antimicrob. Chemother 2003; 51: 1327–1330
   PubMed Web of Science ®Google Scholar
• Marquardt H., Westendorf J., Schaefer A., Boldt J., De Clercq E., Marquardt H. Mutagenic and antimutagenic effects of 5-substituted 2′-deoxyuridines depending on the nature of the 5-substituent. Arzneimittelforschung 1988; 38(12)1820–1824
   PubMed Web of Science ®Google Scholar
• Maron D., Ames B. Revised methods for the Salmonella mutagenicity test. Mutat. Res 1983; 113: 173–215
   PubMed Web of Science ®Google Scholar
• Matsushima T., Sawamura M., Hara K., Sugimura T. A safe substitute for polychlorinated biphenyls as an inducer of metabolic activation system. In vitro Metabolic Activation in Mutagenesis Testing. Elsevier, Amsterdam 1976; 85
   Google Scholar
• McCann J., Ames B.N. Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion. Proc. Natl. Acad. Sci. U.S.A 1976; 73: 950–954
   PubMed Web of Science ®Google Scholar
• Mitsuya H., Yarchoan R., Broder S. Molecular targets for Aids therapy. Science 1990; 249: 1533–1544
   PubMed Web of Science ®Google Scholar
• Ohta T., Watanabe M., Tsukamoto R., Shirasu Y., Kada T. Antimutagenic effects of 5-fluorouracil and 5-fluorodeoxyuridine on UV-induced mutagenesis in. Escherichia coli. Mutat. Res 1986; 173(1)19–24
   PubMed Web of Science ®Google Scholar
• Ono T., Norimatsu M., Yoshimura H. Mutagenic evaluation of primaquine, pentaquine and pamaquine in the Salmonella / mammalian microsome assay. Mutat. Res 1994; 325: 7
   PubMed Web of Science ®Google Scholar
• Rosenkranz H. S., Poirier L. A. Evaluation of the mutagenicity and DNA modifying activity of carcinogens and noncarcinogens in microbial systems. J. Natl. Cancer. Inst 1979; 62: 873–891
   PubMed Web of Science ®Google Scholar
• Schapper R. M., Glickman B. W., Loeb L. A. Role of depurination in mutagenesis by chemical carcinogens. Cancer Res 1982; 42: 3480–3485
   PubMed Web of Science ®Google Scholar
• Sideropoulos A. S. Physiological and genetic effects of puromycin aminonucleoside on ultraviolet-irradiated Escherichia coli strains. Mutat. Res 1979; 62(3)439–450
   PubMed Web of Science ®Google Scholar
• Simmon V. F. In vitro assays of recombinogenic activity of chemical carcinogens and related compounds with Saccaromyces cevisiae D3. J. Natl. Cancer. Inst 1979; 62: 901–908
   PubMed Web of Science ®Google Scholar
• Tufariello J. 1,3 dipolar cycloaddition chemistry. A. Padwa. Wiley Interscience, Wiley New York 1984; 2: 83
   Google Scholar
• Turner B. G., Summers M. F. Structural biology of HIV. J. Mol. Biol 1999; 285: 1–32
   PubMed Web of Science ®Google Scholar
• Yoshikawa T., Kimura S., Hatano T., Okamoto K., Hayatsu H., Arimoto-Kobayashi S. Pseudouridine, an antimutagenic substance in beer towards N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). Food Chem. Toxicol 2002; 40(8)1165–70
   PubMed Web of Science ®Google Scholar